Influence of Age on Treatment Outcomes in Intermediate or High-Risk Prostate Cancer Treated with Androgen Deprivation Therapy and Radiation Therapy

被引：0

作者：

Bryant, A. K. ^{[1
]}

Kader, K. ^{[2
]}

Mckay, R. ^{[3
]}

Einck, J. P. ^{[1
]}

Parsons, J. K. ^{[4
]}

Kane, C. J. ^{[2
]}

Mundt, A. J., Jr. ^{[1
]}

Murphy, J. D. ^{[1
]}

Rose, B. S. ^{[1
]}

机构：

[1] Univ Calif San Diego, Dept Radiat Med, La Jolla, CA 92093 USA

[2] Univ Calif San Diego, Dept Urol, La Jolla, CA 92093 USA

[3] Univ Calif San Diego, Dept Hematol Oncol, La Jolla, CA 92093 USA

[4] Univ Calif San Diego, La Jolla, CA 92093 USA

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2018年 / 102卷 / 03期

关键词：

D O I：

10.1016/j.ijrobp.2018.07.388

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

SU_25_2244

引用

页码：E103 / E103

页数：1

共 50 条

[1] Treatment timing in localized high-risk prostate cancer treated with radiation and androgen deprivation therapy
Hasan, Shaakir
Lazarev, Stanislav
Gorovets, Daniel
Garg, Madhur
Press, Robert H.
Choi, Isabelle
Simone, Charles B.
[J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
[2] Early biochemical predictors of survival in intermediate and high-risk prostate cancer treated with radiation and androgen deprivation therapy
Patel, Mira A.
Kollmeier, Marisa
McBride, Sean
Gorovets, Daniel
Varghese, Melissa
Chan, Luanna
Knezevic, Andrea
Zhang, Zhigang
Zelefsky, Michael J.
[J]. RADIOTHERAPY AND ONCOLOGY, 2019, 140 : 34 - 40
[3] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
Cagney, Daniel N.
Dunne, Mary
O'Shea, Carmel
Finn, Marie
Noone, Emma
Sheehan, Martina
McDonagh, Lesley
O'Sullivan, Lydia
Thirion, Pierre
Armstrong, John
[J]. BMC UROLOGY, 2017, 17
[4] Heterogeneity in high-risk prostate cancer treated with high-dose radiation therapy and androgen deprivation therapy
Daniel N. Cagney
Mary Dunne
Carmel O’Shea
Marie Finn
Emma Noone
Martina Sheehan
Lesley McDonagh
Lydia O’Sullivan
Pierre Thirion
John Armstrong
[J]. BMC Urology, 17
[5] Androgen Deprivation Therapy in High-Risk Prostate Cancer
Buyyounouski, Mark K.
[J]. ONCOLOGY-NEW YORK, 2010, 24 (09): : 806 - 809
[6] Hypofractionated radiation therapy combined with androgen deprivation therapy for high-risk localized prostate cancer
Lee, Tae Hoon
Pyo, Hongryull
Yoo, Gyu Sang
Jeon, Seong Soo
Seo, Seong Il
Jeong, Byong Chang
Jeon, Hwang Gyun
Sung, Hyun Hwan
Kang, Minyong
Song, Wan
Chung, Jae Hoon
Bae, Bong Kyung
Park, Won
[J]. JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2024, 68 (03) : 333 - 341
[7] Radiation Facility Volume and Survival for Men With Very High-Risk Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy
Sebastian, Nikhil
Goyal, Subir
Liu, Yuan
Janopaul-Naylor, James R.
Patel, Pretesh R.
Dhere, Vishal R.
Hanasoge, Sheela
Shelton, Jay W.
Godette, Karen D.
Jani, Ashesh B.
Hershatter, Bruce
Fischer-Valuck, Benjamin
Patel, Sagar A.
[J]. JAMA NETWORK OPEN, 2023, 6 (08) : e2327637
[8] A Phase 1 study Combining Pexidartinib, Radiation Therapy, and Androgen Deprivation Therapy in Men With Intermediate- and High-Risk Prostate Cancer
Hamid, Muhammad
Heilbrun, Lance K.
Maier, Jordan
Devisetty, Kiran
Connolly, Irene
Kaufman, Isaac
Dobson, Kimberlee
Herroon, Mackenzie K.
Smith, Daryn
Sampson, Sandra
Podgorski, Izabela
Heath, Elisabeth I.
[J]. ADVANCES IN RADIATION ONCOLOGY, 2021, 6 (04)
[9] Recent Trends in the Use of Androgen Deprivation Therapy with External Beam Radiation Therapy for Patients with Intermediate- and High-Risk Prostate Cancer
Yang, D. D.
Orio, P. F., III
Nguyen, P. L.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E151 - E152
[10] Intermediate- to high-risk prostate cancer patient treated with radiation therapy
Raben, David
Lucia, Scott
Glode, Michael
Crawford, E. David
Kavanagh, Brian
Raben, Adam
Ayres, Jennifer
[J]. ONCOLOGY-NEW YORK, 2004, 18 (09): : 1105 - 1110

← 1 2 3 4 5 →